Pages
Dr Chris Clayton appointed as Chief Executive Designate JUCD
The appointment of Dr Chris Clayton as Chief Executive Designate of the NHS Integrated Care Board for Derby and Derbyshire.
Black History Month - Reclaiming Narratives
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/black-history-month-reclaiming-narratives
Annual Member's Meeting (AMM) 2025
AMM (Annual Members Meeting) for DCHS November 2025
https://dchs.nhs.uk/about-us/council-governors/become-member/annual-members-meeting
DCHS reservist’s role in Coronation celebrations
https://dchs.nhs.uk/news/dchs-reservists-role-coronation-celebrations
Belper’s new health centre – a building soon in need of a name!
https://dchs.nhs.uk/news/belpers-new-health-centre-building-soon-need-name
Tracy Allen to step down as chief executive of Derbyshire’s community NHS services
Tracy Allen has announced plans to step down as chief executive of Derbyshire Community Health Services NHS Foundation Trust in September 2024, after 13 years in the role.
https://dchs.nhs.uk/news/tracy-allen-step-down-chief-executive-derbyshires-community-nhs-services
Files
L226 – “Working Together” Patient and Public Involvement (PPI) Information Leaflet
Patient information leaflet about PPI, Patient and Public Involvement.
Tier 3 Weight Management A4 patient information NS.pdf
Tier 3 Weight Management patient information leaflet
Declaration - Staff Nursing.pdf
Staff Nursing Declaration
Outpatient physio FAQs Jan 2022.pdf
DCHS outpatient physio FAQs Jan 2022
Communications Annex V7.pdf
How to communicate with Patients using the communication annexe on SystmOne
Advice for Patients Who are Self Isolating v3.pdf
DCHS Advice for Patients Who are Self Isolating - as indicated on the SOP
Water Safety Governance Policy 1.1
Water, Water Safety Group, Legionella, Pseudomonas Aeruginosa, Legionellosis, Water Management, water flushing.
SOP 8 Transporting of Podiatry Instruments (P16)
SOP 8 Transporting of Podiatry Instruments (P16)
The Management of Warfarin Therapy for Inpatients Guidelines (G233)
The aim of this guideline is to improve the safety of anticoagulant therapy for inpatients under the care of DCHS by: • Providing an evidence-based algorithm for the initiation of warfarin therapy in atrial fibrillation, including the use of a specific SystmOne template for warfarin management. • Offering an evidence-based algorithm to guide maintenance dosing decisions. • Clarifying the process for communicating follow-up arrangements to primary care teams when a patient is discharged from hospital. • Endorsing the level of competence and training required of clinicians who prescribe warfarin. • Ensuring that the guidance will be built into an audit and review cycle.
How to Prepare your Election Statement Final 2021
How to Prepare your Election Statement Final 2021